What is Eli Lilly's new weight-loss pill called?

Eli Lilly's new weight-loss pill is called orforglipron.

How does orforglipron compare to Novo Nordisk's weight-loss pill?

Orforglipron offers greater convenience as it can be taken at any time, unaffected by food, unlike Novo Nordisk's pill which requires fasting.

When is Eli Lilly's orforglipron expected to be approved in the U.S.?

Eli Lilly is confident in supplies ahead of its anticipated U.S. approval in the coming months, with a fast-track review potentially speeding up the process.

Home / Health / Lilly Pill: Weight Loss Convenience Ahead

Lilly Pill: Weight Loss Convenience Ahead

12 Jan

•

Summary

Eli Lilly is confident in supplies for its new weight-loss pill.
The drug, orforglipron, received FDA fast-track review, speeding approval.
Lilly's pill offers convenience over rivals by not requiring specific timing with food.

Lilly Pill: Weight Loss Convenience Ahead

Eli Lilly announced on Monday its confidence regarding the supply chain for its new weight-loss pill, orforglipron, in anticipation of its U.S. market approval in the coming months. The pharmaceutical giant is preparing for a swift international launch.

The drug has been granted a fast-track review by the U.S. Food and Drug Administration, a designation that could reduce the typical review period from ten to twelve months down to just one to two months. This expedited process signals a strong potential for a timely market entry.

Daniel Skovronsky, head of research and development at Eli Lilly, highlighted the pill's convenience as a key differentiator against competitors like Novo Nordisk. Unlike some existing weight-loss medications that require specific fasting conditions before administration, orforglipron can be taken at any time, independent of meals, offering patients greater flexibility.